BioWorld

May 30, 2008

View Archived Issues

Kosan's Cancer Pipeline Attracts $5.50 Per Share BMS Buyout Bid

Kosan Biosciences Inc. is being snatched up by Bristol-Myers Squibb Co. for $5.50 per share, becoming the latest acquisition as big pharma struggles to fill dwindling pipelines. (BioWorld Today) Read More

FDA Documents Critical of Ligand's Promacta

Read More

Onconase Misses Endpoint, Rolling NDA to Proceed

Read More

NewCo News: EnzymeRx Makes a $14 Million Start with Uricase Acquisition

Read More

Drug Labeling Rule Proposed for Those Pregnant, Breastfeeding

Read More

Favrille Laying Off 132 After Specifid Fails Pivotal Trial

Read More

Other News To Note

Read More

Clinic Roundup

Read More